Cogent Biosciences, Inc. (COGT) stock
COGTNasdaqPharmaceutical PreparationsFiscal year ends December 31
$27.81−0.04 (-0.14%)
Close on Nov 18, 2026Market cap $4.83BP/E –Yield –
Cogent Biosciences market cap
Market capitalization is the share price multiplied by the number of shares outstanding.
Cogent Biosciences's market cap was $5.04B on Nov 11, 2026, against $5.62B a year earlier. Over the last 5 years it ranged from $211.23M to $6.65B, with a median of $896.91M.
Market Cap at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | $5.04B | +1.6% |
| 2025 | Dec 31, 2025 | $4.97B | +476.5% |
| 2024 | Dec 31, 2024 | $861.57M | +70.1% |
| 2023 | Dec 29, 2023 | $506.41M | -37.3% |
| 2022 | Dec 30, 2022 | $807.56M | +136.2% |
| 2021 | Dec 31, 2021 | $341.92M | +185.2% |
| 2020 | Dec 31, 2020 | $119.91M | +443.0% |
| 2019 | Dec 31, 2019 | $22.08M | -83.2% |
| 2018 | Dec 31, 2018 | $131.67M | – |
See a number that looks wrong?